The Human Enhancement Drugs Network (HEDN) was established in February 2015 and since then has rapidly been growing. We currently have around 80 members of various backgrounds from 15 different countries.
We can truly say that HEDN is a multi-disciplinary and international network including scholars, healthcare providers, anti-doping professionals and various other stakeholders active in the field of human enhancement drugs.
We thought it was high time to thank our members and to inform them of HEDN’s achievements and future plans by developing HED Matters! HED Matters contains articles on current enhancement drugs issues and news.
It will be published on a bi-annual basis. Each edition will have its own theme, highlighting various topics related to the use of human enhancement drugs.
In this edition the focus will be on anabolic androgenic steroids (AAS) and other performance and image enhancing drugs (PIEDs). HED Matters
We can truly say that HEDN is a multi-disciplinary and international network including scholars, healthcare providers, anti-doping professionals and various other stakeholders active in the field of human enhancement drugs.
We thought it was high time to thank our members and to inform them of HEDN’s achievements and future plans by developing HED Matters! HED Matters contains articles on current enhancement drugs issues and news.
It will be published on a bi-annual basis. Each edition will have its own theme, highlighting various topics related to the use of human enhancement drugs.
In this edition the focus will be on anabolic androgenic steroids (AAS) and other performance and image enhancing drugs (PIEDs). HED Matters
